🇺🇸 FDA
Patent

US 9499597

Methods and compositions for treating Huntington's disease

granted A61KA61K38/1709A61P

Quick answer

US patent 9499597 (Methods and compositions for treating Huntington's disease) held by Sangamo Biosciences, Inc. expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/1709, A61P, A61P25/14, A61P43/00